Twitter-1933902270107730032
Addressing Afib in CABG is critical because ignoring it can result in up to a 24% higher 10-year mortality.
However, patients often leave the or with their Afib untreated despite a Class I indication.
Addressing Afib in CABG is critical because ignoring it can result in up to a 24% higher 10-year mortality.
However, patients often leave the or with their Afib untreated despite a Class I indication.
Powerful presentations at the Lunch Symposium today at <a href="https://twitter.com/hashtag/STSCoronary2025.?src=hashtag_click" target="_blank">#STSCoronary2025.</a>
Leading surgeons, including Dr. Cox and Dr. Rushing, emphasized the importance of treating Afib in CABG patients – not just to manage symptoms, but to help restore normal sinus rhythm and improve long-term
With high recurrence rates, esophageal risks & more, EP Dr. Zayad Eldadah walks through the challenges of an endo-only approach to LSPAF treatment.
Discover how the Hybrid Convergent procedure could be the right treatment option for your LSPAF patients: <a href="https://t.co/JRYQOdzU1f" target="_blank">https://t.co/JRYQOdzU1f</a>
Welcome to the 8th Hybrid AF™ Therapies Summit in London, UK! This event is a chance for cardiothoracic surgeons and electrophysiologists to share skills, best practices, and improve complex AF outcomes.
Learn more about Hybrid Therapies and their role in advancing patient care: <a href="https://lnkd.in/eFVHFrbj" target="_blank">https://lnkd.in/eFVHFrbj</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=afibmanagement&highligh…; target='_blank'>#afibmanagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>
After discharge, patients are left with fewer pain management options. Addressing and providing patients with the right pain management approach can make all the difference during recovery.
Discover more about the impact of transitional pain at: <a href="https://t.co/qDhqUhYHeu" target="_blank">https://t.co/qDhqUhYHeu</a>
Our people make us a Top Workplace, and we’re thrilled to be recognized by <a href="https://twitter.com/StarTribune" target="_blank">@StarTribune</a> as a 2025 Top Workplace for our Minneapolis office!
Empowered teams and passionate people lead to better patient care.
<a href="https://twitter.com/hashtag/ThisisAtriCure?src=hashtag_click" target="_blank">#ThisisAtriCure</a> <a href="https://twitter.com/hashtag/Topworkplace?src=hashtag_click" target="_blank">#Topworkplace</a>
Our people make us a Top Workplace, and we’re thrilled to be recognized by Star Tribune as a 2025 Top Workplace for our Minneapolis office!
Empowered teams and passionate people lead to better patient <a href="https://www.facebook.com/hashtag/care
ThisisAtriCure" target="_blank">care.
#ThisisAtriCure</a> <a href="https://www.facebook.com/hashtag/Topworkplace" target="_blank">#Topworkplace</a>
We’re just one day away from the Hybrid AF™ Therapies Summit in London. We look forward to welcoming participants for a full day of scientific exchange focused on hybrid approaches to treating persistent and long-standing persistent AF.
Learn more about Hybrid Therapies: <a href="https://lnkd.in/eFVHFrbj" target="_blank">https://lnkd.in/eFVHFrbj</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=afibmanagement&highligh…; target='_blank'>#afibmanagement</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=HybridAFTherapy&highlig…; target='_blank'>#HybridAFTherapy</a>
Medications and conventional ablation techniques have been used to treat IST symptoms, but neither option is fully effective. That's why hybrid ablation is being studied for safety and effectiveness in the HEAL-IST Trial.
Learn more about the HEAL-IST Trial at:
Do you have inappropriate sinus tachycardia (IST)? If you've become resistant or intolerant to your medications, you may be a candidate for the HEAL-IST Trial.
For participation criteria and study details, visit HEAL-IST.com